Programme Thesis
The French Tech Grant is a state-backed early-stage funding instrument designed to support founders who can demonstrate technical depth, market fit, and alignment with French national priorities such as deeptech, health, and research commercialization. It exists to provide non-dilutive runway for validation and R&D, while rewarding clear application logic and measurable proof over generic ideas.
Selection Criteria
- Technical depth and proof-of-concept strength
- Market fit and commercial potential
- Alignment with French public priorities (deeptech, health, industrial tech, climate, digital sovereignty, export potential)
- Clarity of application logic: stage definition, risk reduction, budget tied to measurable proof, reporting plan
- Feasibility and believability of growth path
- For deeptech versions: scientific depth, lab partnerships, patents, or hard technical barriers
Past Winners / Cohort Profiles
The page does not list specific past winners, but describes typical winners as early-stage startups in deeptech, industrial tech, climate, health, energy, digital sovereignty, and research commercialization. They often have strong technical proof, clear market fit, and a believable path to growth, and they stack multiple funding tools (grants, tax credits, loans) to extend runway.
Ideal Candidate Fingerprint
The platonic ideal applicant is a deeptech founder with a validated proof-of-concept, strong technical background, and a clear alignment with French national priorities such as health or research commercialization. They present a concise application that defines their stage, shows what risk the grant will reduce, ties budget to measurable proof, and plans for reporting, while demonstrating a path to market and export potential.
Recommended Framing
For Eniola Olutogun, the strongest angle is to frame the venture as a deeptech health innovation that directly addresses French priorities in health and research commercialization, leveraging the validated proof-of-concept (AUROC 0.804 on Platinum) and the planned fine-tuning on SKEMPI to reach AUROC ≥0.70. The application should emphasize the technical depth of the ESM-2 delta-embeddings approach, the 100% mutation coverage advantage over structure-limited tools, and the clear roadmap to a Servier pilot, which aligns with the programme's preference for research-led projects with commercial potential. The founder's pharmacist-turned-ML-engineer background and the named partnerships with Paris-Saclay and Institut Pasteur further strengthen the fit.
Watch Out
The venture is not yet incorporated, which may be a requirement for some French grants; the programme's exact eligibility is unknown. Also, the grant amount (€10K-€30K for early-stage) may be small relative to the venture's needs, and the application must clearly demonstrate how the grant will reduce specific risks and lead to measurable outcomes.
Research History
2026-08-04 20:17 · medium confidence
2026-08-01 17:30 · medium confidence